AI assistant
CALIX, INC — Director's Dealing 2021
Oct 8, 2021
31174_dirs_2021-10-07_c00f4da7-af2f-41d1-9109-184f0eba4949.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CALIX, INC ((CALX))
CIK: 0001406666
Period of Report: 2021-09-25
Reporting Person: Collins John Matthew (EVP, Commercial Operations)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $6.95 | 2027-08-01 | Common Stock (71000.0) | Direct | |
| Stock Option (right to buy) | $8.03 | 2029-02-14 | Common Stock (45000.0) | Direct | |
| Stock Option (right to buy) | $9.16 | 2030-01-31 | Common Stock (200000.0) | Direct |
Footnotes
F1: 100% of the shares subject to the option grant were fully vested and exercisable on August 1, 2021.
F2: On February 14, 2019, the reporting person was awarded a performance-based nonqualified stock option grant covering 150,000 shares of common stock. On February 13, 2020, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 30% of the grant had been achieved. Each nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 13, 2020; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 13, 2020. As of September 25, 2021, 28,125 shares subject to the option grant are fully vested and exercisable.
F3: On January 31, 2020, the reporting person was awarded a performance-based nonqualified stock option grant covering 200,000 shares of common stock. On February 13, 2021, the Compensation Committee of Calix, Inc. determined that the performance criteria governing the grant had been achieved. Each nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on January 31, 2021; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from January 31, 2021. As of September 25, 2021, 75,000 shares subject to the option grant are fully vested and exercisable.